Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ergosterol-containing fungal cell membrane** refers to the unique lipid bilayer found in fungi that incorporates **ergosterol** as its principal sterol component. Ergosterol serves many roles analogous to cholesterol in animal cells—it regulates **membrane fluidity**, controls permeability, stabilizes embedded proteins, and supports proper localization of key enzymes involved in processes such as nutrient transport and signal transduction. Disruption or alteration of ergosterol content leads to profound changes in the physical properties of the plasma membrane—affecting not only its structural integrity but also critical biological functions such as maintenance of the cell wall and virulence factors. Because mammalian cells do not contain ergosterol (using cholesterol instead), this molecule—and thus the entire ergosterol-rich fungal plasma membrane—serves as a highly selective target for several major classes of antifungal agents including polyenes like amphotericin B (which bind directly to ergosterol) and azoles like fluconazole or miconazole (which inhibit its biosynthesis). This selectivity underpins both their therapeutic utility against invasive mycoses as well as some safety challenges related primarily to drug toxicity or resistance development.
Amphotericin B binds to ergosterol in the fungal cell membrane, forming pores that disrupt ion balance and cause cell death by leakage of cellular contents. Azole antifungals (fluconazole, miconazole, itraconazole, clotrimazole) inhibit ergosterol biosynthesis by blocking 14α-demethylase, leading to defective membranes and impaired fungal growth.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ergosterol-containing fungal cell membrane.